Major AUD$280 million investment to deliver mRNA 2.0
Sanofi, one of the world’s largest vaccine innovators, has partnered with the Queensland Government to inject AUD$280 million into next generation mRNA vaccine research in Queensland.
Sanofi and Queensland Premier Annastacia Palaszczuk today announced the creation of the Translational Science Hub, which will connect top researchers in Queensland with those at the Sanofi mRNA Centre of Excellence in France and the US. This will result in a distinct mRNA technology and translational science-focused worldwide vaccination research and development network.
This ground-breaking collaboration between the University of Queensland and Griffith University will put Queensland at the forefront of Australian biomedical research and vaccine development. Initial focus for the Translational Science Hub will be on the
Chlamydia is a sexually transmitted infection (STI) that is becoming more common. A new generation of mRNA vaccines are being evaluated, and a world-first mRNA vaccine is being developed.
Due to its link to infertility, pelvic inflammatory disease, and pregnancy problems, it is a public health concern.
mRNA is expected to herald a new generation of vaccines that instruct certain cells to produce proteins that are recognised by the immune system to mount a defence.